Physician profile
Rohit Kashyap
NPI 1902845209
$4,279.15
in general payments reported to CMS, 2019-2025
17 companies · $258 in 2025
The $258 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2021: $176 · 2022: $2,338 · 2023: $522 · 2024: $595 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,375.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,206.40 | 2022 | |
| Merit Medical Systems INC | $571.26 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $537.94 | 2019-2023 | Lokelma |
| Aurinia Pharma U.S., INC. | $337.27 | 2022-2023 | Lupkynis |
| Travere Therapeutics, INC. | $286.21 | 2023-2024 | |
| Ardelyx, INC. | $238.19 | 2024-2025 | Xphozah 30 Mg |
| Amgen INC. | $195.35 | 2024 | Tavneos |
| Vifor Pharma, INC. | $129.44 | 2024 | |
| Horizon Therapeutics Plc | $124.43 | 2023 | Krystexxa |
| Glaxosmithkline, LLC. | $123.97 | 2022 | |
| Apellis Pharmaceuticals, INC. | $122.31 | 2025 | Empaveli |
| Bayer Healthcare Pharmaceuticals INC. | $110.85 | 2022 | |
| Baxter Healthcare | $101.57 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $88.77 | 2019 | |
| Nxstage Medical, INC. | $73.95 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $17.55 | 2024 | Pristine |
| Novartis Pharmaceuticals Corporation | $13.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Kashyap listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.